Hindustan Unilever Ltd (HINDUNILVR) Q2 FY27 Earnings Call: 15% USG Best in 14 Quarters, Widens EBITDA Margin Guidance to 22-24%

Hindustan Unilever Ltd held its Q2 FY27 earnings call on October 28, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Best USG in 14 Quarters, Volume-Led

• Rs.18,071 Cr turnover with 15% USG — highest underlying sales growth in the last 14 quarters, with 7% UVG on 8% UPG; management framed strong volumes despite price increases as evidence of brand strength and portfolio resilience.
• PAT before exceptional items up 9% YoY to Rs.2,795 Cr — absolute EBITDA up 8% YoY to Rs.4,089 Cr at a 22.6% margin, well within the guided range; reported PAT flat YoY as the Q2 FY 2025-2026 base included Rs.273 Cr of one-off tax-related gains.
• H1 FY 2026-2027 turnover of Rs.35,255 Cr — 12% USG, 6% UVG and 9% PAT BEI growth, attributed to dynamic resource allocation under the value creation model.
• Interim dividend of Rs.19 per share — approved by the Board for the financial year ending 31 March 2027 (FY 2026-2027).
• Gross margin contracted close to 400 bps in Q2 FY 2026-2027 — yet EBITDA margin rose 140 bps YoY, with the 260 bps bridge recovered via other-expense operating leverage and A&P efficiencies rather than A&P cuts, per CFO Niranjan Gupta.
• Sequential EBITDA margin decline limited to 40 bps — CFO said Q1 and Q2 FY 2026-2027 bore the brunt of input cost inflation and inflation of that magnitude is unlikely to recur going forward.

Home Care & Beauty Lead; Tea Subdued

• Home Care USG of 22% on double-digit UVG — fabric wash grew strong double-digit across bars, powders and liquids; Surf Excel Easy Wash and the Rs.99 powder delivered double-digit growth; household care and home care liquids double-digit volume-led.
• Beauty & Well-being USG of 16% on double-digit UVG — recovered from 2% in Q2 FY 2025-2026; CEO Priya Nair told UBS's Amit Sachdeva the momentum is structural, spanning brand desirability, portfolio transformation, channel execution, R&D science and supply chain agility.
• Personal Care and Foods each delivered 9% USG — a sequential step-up; skin cleansing grew double-digit (Pears, Dove bars), while oral care was low single-digit with premium innovations up double-digit; coffee grew high single-digit on volumes.
• Tea subdued in Q2 FY 2026-2027 — particularly mass teas where inflation levels were high, while Red Label instant tea scaled well; management is watching how the category evens out as tea inflation settles.
• Minimalist growth accelerated sequentially as offline presence expanded; health & well-being remained subdued despite healthy category fundamentals.
• Market shares improved at company level and in Home Care — CFO confirmed, with Nair attributing performance to brand work and execution fundamentals while noting "there will always be cyclicity."

Passing Through Absolute Cost, Protecting Volumes

• 8% UPG alongside 7% UVG in Q2 FY 2026-2027 — CFO Niranjan Gupta said the strategy in inflationary times is to pass on the absolute cost fully through pricing, then leverage A&P productivity and overhead leverage on other P&L lines.
• Home Care EBIT margin of 16% on revenue close to Rs.7,000 Cr — framed as cyclical, not structural: steep petrochemical-based input cost inflation creates a price-vs-cost lag; management advised focusing on absolute profit growth during inflationary periods.
• Home Care pricing deliberately passes on absolute cost — to protect the consumer franchise and improve competitiveness; management said the portfolio is premium-weighted and leader in fabric conditioners and liquids, so margin pressure is not a structural change.
• Tea pricing has covered cost — CEO Priya Nair: "the answer is yes, we have covered cost" on tea, where much of the required pricing has been taken; an analyst cited a peer player taking another 8% price increase on tea solely (period unspecified).
• Elasticity limited for everyday essentials — Nair noted laundry, dishwash, tea and soaps historically show much less elasticity than discretionary categories, with the portfolio straddling the pyramid from mass (Wheel) to premium providing spread against cyclicality.
• Calibrated price increases to continue in H2 FY 2026-2027 — as inflation moves up; management flagged that "some part of the rebalancing" between price and volume may happen, though elasticity has been visible for six months and was flagged as early as Q4 FY 2025-2026.

Go-to-Market Expansion and Spend Reallocation

• 30,000 general trade outlets added in Q2 FY 2026-2027 — with healthy double-digit assortment growth; modern trade asset deployment nearly doubled over H1 FY 2026-2027; e-commerce and quick commerce saw technology-led sequential service-level improvements.
• Quick commerce "very beneficial" for HUL — per Priya Nair, it creates a channel for premium products targeted at affluent consumers; management is working with all quick commerce players to build categories, and supply to smaller towns is mostly direct.
• Home care A&P cut by almost Rs.250 Cr in Q2 FY 2026-2027 — reflecting input cost pressures, while absolute spends increased in all other categories where pricing passed on was lower; ad spends remained competitive after reallocation.
• SOS/SOM ratios on traditional media improved from 1 to 1.1 — in Q2 FY 2026-2027; CFO said ad spend-to-sales ratio is "not the right metric" after BNP Paribas's Kunal Vora noted the A&P-to-sales ratio is near its lowest point in almost 20 years.
• 10% savings in A&P spend (period unspecified) — as presented at Capital Markets Day, arising from non-working media, use of AI tools and buying efficiency.
• New launches: Horlicks protein powder and Simple barrier repair range — Horlicks extended into the fast-growing protein segment in Q2 FY 2026-2027 with encouraging early traction; Simple's pro-ceramides range reinforces its sensitive-skin expertise.

Widened Range, No Sub-Segment Commitments

• Near-term EBITDA margin guidance of 22-24% (period unspecified) — CFO Niranjan Gupta explained the range was expanded by 50 bps on either side because cyclicity can at times take margins to the lower end.
• Q2 FY 2026-2027 margin cited within a 20-24% guided range in Q&A — the CFO noted margins are cyclical but the portfolio is structurally positioned toward higher margins, as laid out at the capital markets day.
• 25% pre-COVID peak margin aspiration — asked whether it is fair over the next 3-5 years, the CFO answered structurally rather than committing to a numeric target: over the next 3 to 5 years the portfolio moves toward a higher margin profile via premiumization in personal care (Dove, Pears) and foods (premium tea, premium innovations).
• Gross margin trajectory — an analyst noted gross margin was ~53% pre-COVID and later settled around 51%, asking whether HUL can exit around 50-51% by Q4 FY 2026-2027 or early FY 2027-2028; the CFO declined to give a number, stating over a 3-5 year medium-term horizon the portfolio is "structurally positioned for improvement in gross margin," while the next one-two quarters remain subject to cyclicals.
• Management declined guidance on Home Care margins realigning to the historical 19-20% range — reiterating focus on volume-led revenue and profit growth rather than sub-segment margin targets.
• D2C ad-spend dilution: "not for us" — the CFO said growth comes through four pillars (consumption, premiumization, market making, white spaces), with big bets and new entries fully funded and calibration between investment and top-line/bottom-line growth.

Resilient Demand, Rural Stepping Up

• Indian GDP grew 7.8% in Q1 FY 2026-2027 — with high-frequency indicators remaining healthy in Q2 FY 2026-2027 and demand conditions positive; the global geopolitical environment is volatile and commodity prices elevated.
• Rural growth stepped up sequentially over the last 4 quarters — through Q2 FY 2026-2027, per CFO Niranjan Gupta responding to Ajay Thakur (Anand Rathi Securities); rural demand "as of now remains positive."
• Rural incomes insulated from agri stress — agriculture's contribution to GDP has declined over 20 years to just 15% (current level as of Q2 FY 2026-2027), cushioned by MSP increases and MGNREGA benefits, with 30-35% of rural incomes from non-agri sources.
• H2 FY 2026-2027 outlook qualitative, no quantified guidance — responding to analyst concerns on poor monsoon, rising inflation, price elasticity and a higher base, the CFO noted momentum has improved over the last 3-4 quarters and base comparisons are not like-for-like since volume growth comes on high price growth.
• Wellness slowdown acknowledged — Priya Nair said the wellness market remains small and niche with low penetration concentrated among affluent consumers; Oziva's two-year CAGR since acquisition is running at strong double digits, and management expressed confidence the slowdown will be fixed from Q3 FY 2026-2027 onward.
• Lifebuoy underperformance flagged by Percy Panthaki (IIFL Capital) — Nair noted Lifebuoy is a mass brand in a category uptrading to HUL's own brands, cited the Lifebuoy Ice Bar launch with more work to come, while Dettol performs exceedingly well on the germ-control platform.
• Risks to monitor — management will continue to monitor inflation and any monsoon-led impact on crops; medium-term, management expects the demand environment to remain resilient and commodity inflation to stay elevated.